Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Oct 7, 2021; 27(37): 6290-6305
Published online Oct 7, 2021. doi: 10.3748/wjg.v27.i37.6290
Figure 4
Figure 4 10-year overall surviving and relapse-free surviving of patients with T3-4N1-2M0 stages of gastric cancer depending on the presence of antibiotic therapy 1-1. 5 mo before surgery (P = 0.78). A: 10-year overall surviving; B: Relapse-free surviving.